---
document_datetime: 2023-09-21 18:43:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zoledronic-acid-mylan-epar-all-authorised-presentations_en.pdf
document_name: zoledronic-acid-mylan-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8726186
conversion_datetime: 2025-12-25 12:23:48.986519
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name       | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Pack size                   |
|------------------|-----------------------|------------|---------------------------------------|---------------------------|-----------------------|-----------------------------|
| EU/1/12/786/001  | Zoledronic acid Mylan | 4 mg/5ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 1 vial                      |
| EU/1/12/786/002  | Zoledronic acid Mylan | 4 mg/5ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 4 vials                     |
| EU/1/12/786/003  | Zoledronic acid Mylan | 4 mg/5ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 vials                    |
| EU/1/12/786/004  | Zoledronic acid Mylan | 4 mg/5ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 4 (4 x 1) vials (multipack) |